Benjamin Enerson

General Counsel bei THESEUS PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Health Services

Profil

Benjamin Enerson is currently working as Vice President-Legal Affairs at Theseus Pharmaceuticals, Inc. Prior to this, he worked as General Counsel at Finch Therapeutics Group, Inc. and Tremeau Pharmaceuticals, Inc. He completed his undergraduate degree from Vanderbilt University and his graduate degree from Cornell Law School in 2004.

Aktive Positionen von Benjamin Enerson

Unternehmen	Position	Beginn
THESEUS PHARMACEUTICALS, INC.	General Counsel	-

Alle aktiven Positionen von Benjamin Enerson

Ehemalige bekannte Positionen von Benjamin Enerson

Unternehmen	Position	Ende
FINCH THERAPEUTICS GROUP, INC.	General Counsel	-
Tremeau Pharmaceuticals, Inc. Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA.	General Counsel	-

Sehen Sie sich die Erfahrung von Benjamin Enerson im Detail an

Ausbildung von Benjamin Enerson

Cornell Law School	Graduate Degree
Vanderbilt University	Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Benjamin Enerson im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
FINCH THERAPEUTICS GROUP, INC.	Health Services

Private Unternehmen	2
Theseus Pharmaceuticals, Inc. Theseus Pharmaceuticals, Inc. BiotechnologyHealth Technology Theseus Pharmaceuticals, Inc. engages in the development of pan-variant kinase inhibitors. It focuses on the discovery, development and commercialization of transformative targeted therapies. The company was founded by William C. Shakespeare, David C. Dalgarno, Iain D. Dukes, Wei Sheng Huang and Victor M. Rivera on December 29, 2017 and is headquartered in Cambridge, MA.	Health Technology
Tremeau Pharmaceuticals, Inc. Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA.	Health Technology